Chromotherapy in reducing anxiety level of patients with oral malignancies and patients apprehensive of oral cancer

Chromotherapy in reducing anxiety level of patients with oral malignancies and patients apprehensive of oral cancer - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/02/103845

Enrollment

159

Registered

2026-02-13

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C148- Malignant neoplasm of overlappingsites of lip, oral cavity and pharynx

Interventions

Intervention1: Chromotherapy: Patients were given score sheet to measure their anxiety levels. Hospital Anxiety and depression scale (HANS) The scale consists of 7 questions for anxiety and 7 questio

Eligibility

Inclusion criteria

Inclusion criteria: Patients with normal vision

Exclusion criteria

Exclusion criteria: Patients below 30 years of age Patients without consent Pregnant women

Design outcomes

Primary

Measure	Time frame
There is significant reduction in the anxiety level of pateints in the interventional group receiving ChromotherapyTimepoint: T0 - before giving intervention T1 - after giving intervention	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactKiruppashini T

PG student

tkapple34@gmail.com9894443439

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026